Wilson Encourages Investors Who Suffered Losses In Neumora To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Neumora pursuant and/or ...
The Gross Law Firm issues the following notice to shareholders of Neumora Therapeutics, Inc. . Shareholders who purchased shares ...
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Immunocore Holdings (IMCR – Research Report), ...
If you purchased or acquired securities in Neumora pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issu ...
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today and set a price target of ...
William Blair lowered shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) from an outperform rating to a market ...
Fintel on MSN5d
Guggenheim Downgrades Neumora Therapeutics (NMRA)Fintel reports that on March 10, 2025, Guggenheim downgraded their outlook for Neumora Therapeutics (NasdaqGS:NMRA) from Buy ...
WASHINGTON-Republicans are charging ahead with a proposal endorsed by President Trump that would keep the government funded into the fall while reducing spending, setting up a clash with Democrats ...
Detailed price information for Neumora Therapeutics Inc (NMRA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback